Your browser doesn't support javascript.
loading
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Pender, Michael P; Csurhes, Peter A; Smith, Corey; Beagley, Leone; Hooper, Kaye D; Raj, Meenakshi; Coulthard, Alan; Burrows, Scott R; Khanna, Rajiv.
Affiliation
  • Pender MP; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia m.pender@uq.edu.au.
  • Csurhes PA; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
  • Smith C; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Beagley L; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Hooper KD; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Raj M; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Coulthard A; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Burrows SR; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Khanna R; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Mult Scler ; 20(11): 1541-4, 2014 Oct.
Article in En | MEDLINE | ID: mdl-24493474
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Herpesvirus 4, Human / CD8-Positive T-Lymphocytes / Epstein-Barr Virus Infections / Multiple Sclerosis, Chronic Progressive Limits: Adult / Humans / Male Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2014 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Herpesvirus 4, Human / CD8-Positive T-Lymphocytes / Epstein-Barr Virus Infections / Multiple Sclerosis, Chronic Progressive Limits: Adult / Humans / Male Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2014 Document type: Article Affiliation country: Australia Country of publication: United kingdom